Q2 2026 13F · SEC CIK 1540358
a16z Capital Management, L.L.C.
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $14.2B
- Reported positions
- 19
- Top holdings a year, 3 yrs
- +64.0%
- Assets under management
- $106.5B
a16z Capital Management, L.L.C. is a hedge fund that reported 19 positions worth $14.2B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Space Ex Tech Spacex Class A (SPCX, 90.0%), Navan Inc (NAVN, 4.5%), Revolution Medicines Inc (RVMD, 1.2%). A portfolio copying its top holdings returned 64.0% a year over the last 3 years, against 18.4% for the S&P 500.
a16z Capital Management, L.L.C. holdings all 19 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| SPCXSpace Ex Tech Spacex Class A | 90.0% | — | $12.8B |
| NAVNNavan Inc | 4.5% | +0.0% | $645.4M |
| RVMDRevolution Medicines Inc | 1.2% | +0.0% | $172.5M |
| METAMeta Platforms Inc Class A | 0.8% | +0.0% | $119.7M |
| FIGFigma Inc | 0.8% | -62.6% | $108.2M |
| BIOABioage Labs Inc | 0.6% | +0.0% | $79.2M |
| SQBlock Inc | 0.5% | +0.0% | $77.3M |
| ERASErasca Inc | 0.4% | +0.0% | $52.4M |
| MAZEMaze Therapeutics Inc | 0.4% | +0.0% | $50.8M |
| GLTODamora Therapeutics Inc | 0.2% | +0.0% | $32.2M |
| OMDAOmada Health Inc | 0.2% | -50.0% | $25.3M |
| NAUTNautilus Biotechnology Inc | 0.1% | -48.7% | $16.9M |
| RBLXRoblox Corporation | 0.1% | — | $14.9M |
| AKTSAktis Oncology Inc | 0.1% | +0.0% | $13.4M |
| CAMPCAMP4 Therapeutics Corporation | 0.1% | +0.0% | $9.3M |
| BTGOBitgo Holdings Inc | 0.0% | +0.0% | $3.5M |
| KLRAKailera Therapeutics Inc | 0.0% | — | $3.1M |
| DNAGinkgo Bioworks Holdings Inc | 0.0% | +0.0% | $1.1M |
| IPSTIp Strategy Holdings Inc | 0.0% | — | $10K |
What a16z Capital Management, L.L.C. bought and sold in Q2 2026, against Q1 2026.
New positions
- SPCX Space Ex Tech Spacex Class A90.0% of 13F
- RBLX Roblox Corporation0.1% of 13F
- KLRA Kailera Therapeutics Inc0.0% of 13F
- IPST Ip Strategy Holdings Inc0.0% of 13F
Added to
No position grew by more than 5%.
Reduced
- FIG Figma Inc-62.6% shares
- OMDA Omada Health Inc-50.0% shares
- NAUT Nautilus Biotechnology Inc-48.7% shares
Sold out
- Ip Strategy Holdings Incwas 0.0%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +71.9% /yr
- S&P 500 +20.1%
- 3 years
- +64.0% /yr
- S&P 500 +18.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $14.2B | 19 |
| Q1 2026 | $1.3B | 16 |
| Q4 2025 | $1.6B | 13 |
| Q3 2025 | $1.4B | 11 |
| Q2 2025 | $312.9M | 10 |
| Q1 2025 | $700.9M | 13 |
| Q4 2024 | $745.3M | 12 |
| Q3 2024 | $1.1B | 13 |
| Q2 2024 | $1.2B | 13 |
| Q1 2024 | $1.4B | 13 |
| Q4 2023 | $1.6B | 16 |
Questions about a16z Capital Management, L.L.C.'s portfolio
What stocks does a16z Capital Management, L.L.C. own?
a16z Capital Management, L.L.C.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 19 positions worth $14.2B. The largest are Space Ex Tech Spacex Class A (SPCX) at 90.0%, Navan Inc (NAVN) at 4.5%, Revolution Medicines Inc (RVMD) at 1.2%, Meta Platforms Inc Class A (META) at 0.8% and Figma Inc (FIG) at 0.8%.
What did a16z Capital Management, L.L.C. buy last quarter?
In Q2 2026, a16z Capital Management, L.L.C. added a new position in Space Ex Tech Spacex Class A (SPCX), a new position in Roblox Corporation (RBLX), a new position in Kailera Therapeutics Inc (KLRA) and a new position in Ip Strategy Holdings Inc (IPST), compared with its Q1 2026 filing.
What did a16z Capital Management, L.L.C. sell last quarter?
In Q2 2026, a16z Capital Management, L.L.C. sold all of Ip Strategy Holdings Inc, Figma Inc (FIG) (-62.6% shares), Omada Health Inc (OMDA) (-50.0% shares) and Nautilus Biotechnology Inc (NAUT) (-48.7% shares), compared with its Q1 2026 filing.
How has a16z Capital Management, L.L.C.'s portfolio performed?
A portfolio copying a16z Capital Management, L.L.C.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +64.0% a year over the last 3 years, against +18.4% for the S&P 500. Over 1 year: +71.9% against +20.1%.
When is a16z Capital Management, L.L.C.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. a16z Capital Management, L.L.C.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does a16z Capital Management, L.L.C. manage?
a16z Capital Management, L.L.C. reported $106.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $14.2B.